Zobrazeno 1 - 2
of 2
pro vyhledávání: '"V Suryakiran, Pemmaraju"'
Autor:
Zhu, Fengcai, Li, Juan, Hu, Yuemei, Zhang, Xiang, Yang, Xiaoping, Zhao, Hui, Wang, Junzhi, Yang, Jianguo, Xia, Guodong, Dai, Qinyong, Tang, Haiwen, V Suryakiran, Pemmaraju, Datta, Sanjoy K, Descamps, Dominique, Bi, Dan, Struyf, Frank
Publikováno v:
Human Vaccines & Immunotherapeutics
Immunogenicity and safety of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine were evaluated in healthy Chinese females aged 9-45 years in 2 phase IIIB, randomized, controlled trials. Girls aged 9-17 years (ClinicalTrials.gov, NCT00996125
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::82964df65f1f3b6ca5af9dacd2427af6
http://europepmc.org/articles/PMC4186032
http://europepmc.org/articles/PMC4186032
Autor:
Konno, Ryo, Yoshikawa, Hiroyuki, Okutani, Marie, Quint, Wim, V Suryakiran, Pemmaraju, Lin, Lan, Struyf, Frank
Publikováno v:
Human Vaccines & Immunotherapeutics
In this open, extended follow-up study (NCT00929526, Clinicaltrials.gov), we evaluated the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine efficacy, immunogenicity and safety up to 4 years after first vaccination in Japanese women aged 20-25
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5790187e266ff73a4fcb5dba6e657185
http://europepmc.org/articles/PMC4186043
http://europepmc.org/articles/PMC4186043